Results 211 to 220 of about 34,933 (276)

Sjögren's Syndrome with Sensory Neuronopathy and Polyradiculoneuropathy. [PDF]

Intern Med
Funakoshi T, Yamada M, Ikeda K, Yokokawa K, Saito T, Tsuda R, Iwahara N, Suzuki S, Hisahara S.   +8 more
europepmc   +1 more source

Direct Infection of Primary Salivary Gland Epithelial Cells by Human T Lymphotropic Virus Type I in Patients With Sjögren's Syndrome

, 2014
Hideki Nakamura, Yoshiko Takahashi, Tomomi Yamamoto‐Fukuda, Yoshiro Horai, Yoshikazu Nakashima, Kazuhiko Arima, Tatsufumi Nakamura, Takehiko Koji, Atsushi Kawakami   +8 more
openalex   +2 more sources

Pharmacogenomics of Thiopurine Drugs: A Bench‐To‐Bedside Success Story in Thailand

Clinical and Translational Science, Volume 19, Issue 2, February 2026.
ABSTRACT Thiopurine drugs are the cornerstone treatment for many diseases such as acute lymphoblastic leukemia (ALL), organ rejection, inflammatory bowel disease (IBD), systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and other autoimmune diseases.
Mohitosh Biswas, Shobana John, Murshadul Alam Murad, Chonlaphat Sukasem   +3 more
wiley   +1 more source

Hypokalemic Quadriparesis as the Initial Presentation of Sjögren's Syndrome With Distal Renal Tubular Acidosis: A Case Report. [PDF]

Cureus
Sunkari SHB, Nikhare MU, Baig S, Bhoyar JJ.   +3 more
europepmc   +1 more source

First‐in‐Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP1617, a Cathepsin‐S Inhibitor, in Healthy Adult Subjects

Clinical and Translational Science, Volume 19, Issue 2, February 2026.
ABSTRACT ASP1617 is a novel, highly selective inhibitor of cathepsin‐S, an important protease for antigen peptide loading onto major histocompatibility complex class II molecules. Preclinically, ASP1617 prevented progression of lupus‐like glomerulonephritis in an NZB/W F1 mouse model of systemic lupus erythematosus.
Tomoki Kojima, Wei Chen, Ronald Smulders, Stephen Stanhope, Donna Kowalski, Nakyo Heo, Selina Moy, Amanda Goldston, David Han, Tong Zhu   +9 more
wiley   +1 more source

Complete Heart Block in the Fetus: An Antenatal Complication of Sjögren's Syndrome. [PDF]

Life (Basel)
Videnie M, Poalelungi CV, Chiriac A, Bobircă A, Alexandru MC, Ceaușu I.   +5 more
europepmc   +1 more source

AB0156 Polysaccharides from dendrobium officinale ameliorate the development of murine sjögren's syndrome via inducing il-10-producing b cells [PDF]

, 2018
Fan Xiao, Xiang Lin, D. Liu, Liwei Lu
openalex   +1 more source

Factors influencing the EULAR Sjögren's Syndrome Patient-Reported Index in primary Sjögren's syndrome

, 2021
María Graciela Sandoval-Flores, Isela Chan-Campos, Gabriela Hernández‐Molina   +2 more
openalex   +2 more sources

Snapshot Look at Castleman Disease

Journal of Cellular and Molecular Medicine, Volume 30, Issue 3, February 2026.
ABSTRACT Castleman disease (CD) is a rare and heterogeneous group of lymphoproliferative disorders characterised by abnormal proliferation of lymphoid tissue. First described in the 1950s, it has since been classified into two major clinical forms: unicentric CD (UCD), involving a single lymph node region and multicentric CD (MCD), which affects ...
Ciprian Jitaru, Natalia Zlampa, Delia Dima, Anca Bojan, Mihnea Zdrenghea, Laura Urian, David Kegyes, Anamaria Bancos, Maria Santa, Andrei Ivancuta, Bobe Petrushev, Madalina Nistor, Bogdan Tigu, Catalin Constantinescu, Bogdan Fetica, Maria Puiu, Mihai‐Stefan Muresan, Ciprian Tomuleasa   +17 more
wiley   +1 more source

Identification and Validation of Pyroptosis-Associated Gene Signature in Primary Sjögren's Syndrome. [PDF]

Mediators Inflamm
Dai Y, Chen H, Zhou M, Wu C, Gao F, Wang Y, Yan Q, Li Z.   +7 more
europepmc   +1 more source